MedTrace Logo

Inhaled Steroid Treatment as Regular Therapy in Early Asthma

NCT00641914 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 6800

Last updated 2009-03-25

No results posted yet for this study

Summary

A study of the effect of the early treatment with Pulmicort of newly diagnosed asthma. Patients will receive either Pulmicort or a non-active treatment for three years. Neither patients or investigators will be aware of the treatment received. After three years of treatment all patients will receive Pulmicort for 2 further years.

Conditions

Interventions

DRUG

budesonide

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Romain Pauwels · Steering Committee Chairman

  • William Busse · Steering Committee Chairman

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-10-31
Primary Completion
2003-02-28
Completion
2003-02-28

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641914 on ClinicalTrials.gov